Acción ADMS ADAMAS PHARMACEUTICALS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Adamas Pharmaceuticals, Inc.

Acciones

ADMS

US00548A1060

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Adamas Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K
ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Adamas Pharmaceuticals, Inc. Announces Management Changes
Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from NASDAQ Composite Index
Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P TMI Index
Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P Global BMI Index
Supernus Pharmaceuticals, Inc. completed the acquisition of Adamas Pharmaceuticals, Inc. from Mohr Davidow Ventures and others.
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer
Adamas: Q3 Earnings Snapshot
ADAMAS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Adamas Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
North American Morning Briefing : Stock Futures -3-
ADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS
Adamas Pharmaceuticals : Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio - Form 8-K
ADAMAS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
DJ Industrial : US Stocks Drop Monday as Markets Await Big Bank Earnings; Oil Price Advances
Close Update: US Stocks Reverse Earlier Gains as Markets Await Big Bank Earnings; Oil Price Advances
Flexion Therapeutics : Health Care Stocks Sliding in Late Monday Trading
Adamas Pharmaceuticals : Health Care Stocks Drifting Monday as Biotechs Climb
NASDAQ 100 : Top Midday Gainers
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ADMS
  4. Noticias Adamas Pharmaceuticals, Inc.
  5. Otros idiomas